Canaccord Genuity Upgrades Quest Diagnostics (DGX) to Buy
Tweet Send to a Friend
Canaccord Genuity upgraded Quest Diagnostics (NYSE: DGX) from Hold to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE